Rita Medical Systems allies with Aloka

Article

A developer of minimally invasive cancer therapies, Rita Medical Systems, has signed a copromotion agreement with Aloka, a Japanese maker of diagnostic ultrasound equipment. Under

A developer of minimally invasive cancer therapies, Rita Medical Systems, has signed a copromotion agreement with Aloka, a Japanese maker of diagnostic ultrasound equipment. Under terms of the agreement, each company's U.S. sales force will be trained in the others' products to help identify potential common customers. The two companies will also cooperate on formal physician training programs, cosponsor trade show receptions, and display products and promotional materials at each other's booths at industry shows and conferences. Each company will retain direct control of the sales process for its respective products. Ultrasound is often used to visualize and guide the placement of Rita's radio-frequency ablation devices.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.